News

26.10.2017

Reagena was granted a valued recognition by Frost & Sullivan

27.09.2017

Reagena has released for sale a rapid test for the determination of chemokine CXCL13 in human cerebrospinal fluid

13.06.2017

Reagena Oy Ltd and Selinion Medical B.V. sign an exclusive distribution agreement for Benelux countries

06.06.2017

Reagena Oy Ltd and Bestbion dx GmbH sign an exclusive distributor agreement for Germany and Austria